Monitoring minimal residual disease and predicting relapse in APL by quantitating PML-RARalpha transcripts with a sensitive competitive RT-PCR method.

Autor: Tobal, K, Moore, H, Macheta, M, Liu Yin, J A, Yin, J A (AUTHOR)

Publikováno v: Leukemia (08876924). Jul2001, Vol. 15 Issue 7, p1060-1065. 6p.

Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study

Autor: Jovanovic, J.V., Ivey, A., Vannucchi, A.M., Lippert, E., Leibundgut, E. Oppliger, Cassinat, B., Pallisgaard, N., Maroc, N., Hermouet, S., Nickless, G., Guglielmelli, P., Reijden, B.A. van der, Jansen, J.H., Alpermann, T., Schnittger, S., Bench, A., Tobal, K., Wilkins, B., Cuthill, K., McLornan, D., Yeoman, K., Akiki, S., Bryon, J., Jeffries, S., Jones, A., Percy, M.J., Schwemmers, S., Gruender, A., Kelley, T.W., Reading, S., Pancrazzi, A., McMullin, M.F., Pahl, H.L., Cross, N.C., Harrison, C.N., Prchal, J.T., Chomienne, C., Kiladjian, J.J., Barbui, T., Grimwade, D.

Publikováno v: Jovanovic, J V; Ivey, A; Vannucchi, A M; Lippert, E; Oppliger Leibundgut, Elisabeth; Cassinat, B; Pallisgaard, N; Maroc, N; Hermouet, S; Nickless, G; Guglielmelli, P; van der Reijden, B A; Jansen, J H; Alpermann, T; Schnittger, S; Bench, A; Tobal, K; Wilkins, B; Cuthill, K; McLornan, D; ... (2013). Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study. Leukemia, 27(10), pp. 2032-2039. Nature Publishing Group 10.1038/leu.2013.219
Leukemia
Leukemia, 27, 2032-9
Leukemia, 27, 10, pp. 2032-9

Item does not contain fulltext Reliable detection of JAK2-V617F is critical for accurate diagnosis of myeloproliferative neoplasms (MPNs); in addition, sensitive mutation-specific assays can be applied to monitor disease response. However, there has

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8db0b9a0e0a05667e1f59be8f8b90e3d
https://doi.org/10.1038/leu.2013.219

Machine learning and single-cell RNA sequencing reveal relationship between intratumor CD8⁺ T cells and uveal melanoma metastasis.

Autor: Chen, Shuming^1,2 (AUTHOR), Tang, Zichun^1,2 (AUTHOR), Wan, Qiaoqian³ (AUTHOR), Huang, Weidi^1,2 (AUTHOR), Li, Xie^1,2 (AUTHOR), Huang, Xixuan^1,2 (AUTHOR), Zheng, Shuyan^1,2 (AUTHOR), Lu, Caiyang⁴ (AUTHOR), Wu, Jinzheng⁵ (AUTHOR), Li, Zhuo^1,6 (AUTHOR) LiZhuo75@csu.edu.cn, Liu, Xiao^1,2 (AUTHOR) Liuxiao8@csu.edu.cn

Publikováno v: Cancer Cell International. 10/30/2024, Vol. 24 Issue 1, p1-17. 17p.

Molecular Monitoring of Minimal Residual Disease in Acute Myeloblastic Leukemia with t(8;21) by RT-PCR

Autor: Tobal K, Liu Yin Ja

Publikováno v: Leukemia & Lymphoma. 31:115-120

The t(8;21) is one of the most common translocations in acute myeloid leukaemia (AML) occurring in approximately 20% of adult and 40% of paediatric AML-M2. This translocation fuses the AML1 gene on chromosome 21q to the MTG8 (ETO) gene on chromosome

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35fbc74e746dcd578187c7755f729ad0
https://doi.org/10.3109/10428199809057591

New monoallelic (partial tandem duplication) mutation of HNF1a gene in steatotic hepatocellular adenoma

Autor: Sakellariou, S. Morgan, Y. Heaton, N. Portmann, B. Quaglia, A. Tobal, K.

Hepatocellular adenomas (HCAs) containing inactivating HNF1a mutations correspond to a homogenous group of tumors with marked steatosis and no cytological abnormalities or inflammatory infiltrates. We report a case of a 60-year-old woman who was refe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::4c50a1e7c291ca8c48aa535cb670a1e5
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3129521